Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-19725
Publication type: Article in scientific journal
Type of review: Peer review (publication)
Title: Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg depression rating scale, the gold standard clinician rating scale : a meta-analysis of randomised placebo-controlled trials
Authors: Hengartner, Michael Pascal
Jakobsen, Janus C.
Sørensen, Anders
Plöderl, Martin
et. al: No
DOI: 10.1371/journal.pone.0229381
10.21256/zhaw-19725
Published in: PLOS ONE
Volume(Issue): 15
Issue: 2
Pages: e0229381
Issue Date: 2020
Publisher / Ed. Institution: Public Library of Science 
ISSN: 1932-6203
Language: English
Subject (DDC): 616.8: Neurology, diseases of nervous system
Abstract: It has been claimed that efficacy estimates based on the Hamilton Depression Rating-Scale (HDRS) underestimate antidepressants true treatment effects due to the instrument's poor psychometric properties. The aim of this study is to compare efficacy estimates based on the HDRS with the gold standard procedure, the Montgomery-Asberg Depression Rating-Scale (MADRS).
URI: https://digitalcollection.zhaw.ch/handle/11475/19725
Fulltext version: Published version
License (according to publishing contract): Licence according to publishing contract
Departement: Applied Psychology
Organisational Unit: Psychological Institute (PI)
Appears in Collections:Publikationen Angewandte Psychologie

Files in This Item:
File Description SizeFormat 
2020_Hengartner-etal_New-generation-antidepressants.pdf898.34 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.